Pharmacokinetic (PK) model generated based on the single ascending dose (SAD) data and the first multiple ascending dose (MAD ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

This is the summary of “Model-informed identification of optimised dosing strategies for meropenem in critically ill patients ...

Pasithea shares rise as early Phase 1 data of PAS-004 shows strong pERK inhibition and tumor shrinkage in advanced cancer ...

Research and development expenses were $6.7 million for the first quarter ended March 31, 2025, compared to $10.4 million in ...

TransCode Therapeutics advances Phase 1a trial of TTX-MC138 for metastatic cancer with early signs of stability and ...

PK Kemsley asks for joint custody of his kids in response to his estranged wife Dorit Kemsley's divorce filing. The 'Real ...

ISLAMABAD: The Power Division was tasked to complete its homework for the privatisation of three DISCOs (Hesco, Pesco and Fesco) by second quarter of fiscal year 2025-26, a parliamentary panel has ...

On track to report final analysis from IGNITE Phase 2 clinical trial evaluating iluzanebart in ALSP in Q2 2025 – – Plans to ...

Q1 2025 Results Conference Call May 6, 2025 4:30 PM ETCompany ParticipantsBlake Beber - Head, IRSean Saint - President ...